Clinical Trials Browser

Expanded_access × Melanoma × pembrolizumab × Clear all

NCT02083484 2018-01-26

Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)

No longer available

Melanoma

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma